EHR4CR DEPLOYING INNOVATIVE CLINICAL TRIAL SERVICES. Brecht Claerhout, Custodix NV on behalf of the EHR4CR Consortium

Similar documents
TRANSFORMING CLINICAL RESEARCH FOR FASTER ACCESS TO INNOVATIVE MEDICINES. Establishing the Value of EHR4CR for Pharmaceutical Industry

Accelerating Clinical Trials Through Access to Real-World Patient Data

Deliverable 6.4: Final report of EHR4CR Tools and services

THE CONVERGENCE INITIATIVE TO MAXIMISE THE VALUE FROM EUROPEAN RESEARCH

Using EHR data for research purposes Experiences with a Clinical Data Warehouse platform at Hannover Medical School

Panel Discussion on New Business Models

Creation of a pan-european Paediatric Clinical Trials Network. Heidrun Hildebrand (Bayer) & William Treem (Janssen),

The use of electronic Health Records in Clinical Research - The value of CDISC Standards

Coordination and Support Action: Enabling platform on medicines adaptive pathways to patients

Using local RWD to drive global therapeutic advancements.

Update on the IMI2 Proposal to Build a Sustainable pan- European Paediatric Clinical Trials Network

CDISC Journal. Current status and future scope of CDISC standards. By Rebecca D. Kush, President and CEO, CDISC. 1. Introduction

SEMANTIC DATA PLATFORM FOR HEALTHCARE. Dr. Philipp Daumke

KPI Definition Comment Relates to Baseline Target

RBM Risk Based Monitoring GCP Training 12/SEP/2015. Gabor Kiss Synexus Hungary2015

EU Big Data Initiatives

The Transformation of Clinical Research. Health Information Technology Summit. Integration of Policy and Process with Information Technology

DIGITAL REACH INITIATIVE ROADMAP

1201 Maryland Avenue SW, Suite 900, Washington, DC ,

Industrialized Clinical Data Standards Management Speed of automation, Power of accuracy and Transforming clinical data into business intelligence

Webinar IMI2 Call 14 Development of a platform for federated and privacy-preserving machine learning in support of drug discovery

Big Data & Clinical Informatics

Genomics and SNOMED CT (the way ahead) Ian Green Customer Relations Lead, Europe and Clinical Engagement Business Manager

Breakthroughs for Pharmaceutical Organizations

Innovative Medicines Initiative

Topic: Blockchain Enabled Healthcare

IMI WEB-RADR (recognising adverse reactions) project: goals and current activities

BEST PRACTICES GUIDE COMPLYING WITH THE ICH E6(R2) ADDENDUM

Innovative Medicines Initiative (IMI) Future funding opportunities. Catherine Brett, IMI Conferencia H2020 y Salud Madrid, Spain 8 November 2017

Meeting sponsor s criteria : strategy to collaborate, engage and deliver

The Role of Public-Private Partnerships & Evidence Generation

Integrating Standards to Achieve Semantic Interoperability. Dr Ken Lunn Director of Data Standards

Simplifying Clinical Trials

Pan European Paediatric Clinical Trials Network From idea to realization

The European OHDSI Initiative: Why are we here? Peter Rijnbeek Department of Medical Informatics Erasmus MC Rotterdam

Empowering ACO Success with Integrated Analytics

A European Public-Private Partnership! in Healthcare! Michel Goldman, MD,PhD Executive Director

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY

Whitepaper. Tackling Complex Data Challenges in Healthcare Analytics.

ACTIVITY WORK PLAN CONTENTS

The Integration of Market Access and Advocacy: The Changing Landscape OCTOBER 2016

Clinical information systems and translational research:

Immunization Information System Interoperability

The Future of Cancer and Public Health Surveillance A CDC perspective

GLOBAL HEALTH INFORMATICS STANDARDS FOR NATIONAL HEALTH INFORMATION

EBE White Paper on Personalised Medicine

Selecting A Right Patient Recruitment Company: The Key To Success

The pink lines detail the updating made. Dim 1 Dimension 2 Dimension 3

The Future of Clinical and Pharmaceutical Research

CDISC UK Network face to face Reading

Need is accomplished by assessment of current functionality and business needs and identifying gaps and improvement opportunities.

MEDITECH EXPANSE. How do you Measure True Success? // JULY 2018

The Innovative Medicines Initiative: Building new models of collaborative research across Europe

Position Paper. Executive Summary

By Shahid N. Shah, CEO

Technical Steering Committee

Collaborating for the Future Developing effective CRO, Site and Sponsor relationships in a changing healthcare environment

Optimize New Product Development. Presenter s Name Presenter s Title

Webinar IMI2 Call 13 Support and coordination action for the projects of the neurodegeneration area of the Innovative Medicines Initiative



SOA in the pan-canadian EHR

The SAFE Standard: Digital Signatures for Achieving Global, Compliant Requirements for Health Care

INTRODUCING CLINIC AUTOMATION IN A PHASE I UNIT WITH END-TO-END E-SOURCE DATA PROCESSING

HIT Standards for HIM Practices: 2016 Work Plan. AHIMA Standards Task Force Call

Submission of comments on COMMISSION NOTICE ON THE APPLICATION OF ARTICLES 3, 5 AND 7 OF REGULATION (EC) NO 141/2000 ON ORPHAN MEDICINAL PRODUCTS

M*Modal CDI Solutions. Elevating Clinical Documentation Improvement with Artificial Intelligence

US Clinical Research

The interoperability opportunity: Improving healthcare with an end-to-end enterprise strategy

Making the case for Personalised Medicine

M*Modal CDI Solutions

Benefits of Cloud Computing In EHR implementation

An Integrated Approach to Patient Experience Analytics

Supporting and applying research in the NHS. 1. Overview

Agenda. Background SNOMED International Collaborations developments Information models Extensions

FDA Driving Biomedical Product Innovation

BELGIAN USE CASE BASED APROACH AND APPROACH TO TRANSLATION

DEVELOPING CLINICAL TRIALS INFRASTRUCTURE

National Program of Cancer Registries Advancing E-cancer Reporting and Registry Operations (NPCR-AERRO)

1 Copyright 2011, Oracle and/or its affiliates. All rights reserved.

European Induced Pluripotent Stem Cell Bank

ENABLE (IMI) presentation of activities

MANAGING AND INTEGRATING CLINICAL TRIAL DATA: A Challenge for Pharma and their CRO Partners

EUCERD RECOMMENDATION FOR A

How Structured Content Management (SCM) Is Revolutionizing the Life Sciences Industry

THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 118 PATIENT GROUPS with an interest in RESPIRATORY CONDTIONS

CDISC/TransCelerate Collaboration and TransCelerate work streams. -Clinical Data Standards -Common Protocol Template -esource

The Future of Pharmacovigilance

BD4BO and ROADMAP: a collaborative approach to set new standards for the collation and evaluation of RWE in Alzheimer s Disease

MODULE 10 Clinical trials reporting and auditing February 2017

The Open Health Information Exchange (OpenHIE) Community:

Healthcare Integration. Lab data solutions with one simple connection

Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015

IHE-FRANCE Today and future IHE Austrian Day

Corporate Presentation. October 2017

Reimagine: Healthcare

Realizing the National Health IT Strategy Through the Adoption of a Standardized Digital Identity Solution

RWE from pre-clinical to launch. RWE from pre-clinical to launch. Standard of care Unmet needs. Disease burden Budget impact.

NIHR Information Strategy Version 2.0

ABPI response to European Commission consultation on advanced therapy medicinal products

Transcription:

EHR4CR DEPLOYING INNOVATIVE CLINICAL TRIAL SERVICES Brecht Claerhout, Custodix NV on behalf of the EHR4CR Consortium

Electronic Health Records for Clinical Research Re-use of EHR data for optimizing Clinical trials Mandated by IMI One of the largest European public/private partnership projects in this area 4-year project (2011-2015) Extended into 2016 for making the transition to a sustainable platform Budget of >16m For more information: http://www.ehr4cr.eu/ 2

Brings together key stakeholders 35 participants including pharmaceutical industry, academia, hospitals, small and medium-sized enterprises, patient associations and public authorities Advisory boards and other experts 11 hospital sites 3

Background 1993-1997 90 New drugs on market 2008-2012 55 New drugs on market Drug innovation is slowing down Changing landscape Personalised medicine, chronic diseases, ageing population, Increasing Regulatory complexity Economic pressure R&D cost for new chemical / biological entity ~ 1.17 billion (2012) Can Real World Data be a game changer?

EHR4CR Focus: Clinical Trials Incomplete and delayed clinical trials are a sore spot of dug development Waste of costly resources and slow access to new drugs The percentage of studies that complete enrolment on time: 18% in Europe, 7% in the US 1 50% of today s clinical trials fail to achieve the target recruitment rate 4 Almost half of all trial delays caused by patient recruitment problems 2 1/3 of protocol amendments are avoidable, at a cost of $0.5m Each day a drug is delayed from market, sponsors lose 3 up to $8m 1. State of the Clinical Trials Industry: A Sourcebook of Charts and Statistics, Center Watch, 2008. 2. Study Participant Recruitment and Retention in Clinical Trials: Emerging strategies in Europe, the US and Asia, Business Insights, June 2007. 3. Beasley, Recruiting 2008 4. Tufts -http://clinicalperformancepartners.com/wp-content/uploads/2012/07/fixing- Feasibility-Final-Jan-2012.pdf 5

EHR4CR: re-use of EHR data for Clinical Trial optimisation PROTOCOL FEASIBILITY PATIENT RECRUITMENT DATA CAPTURE AND EXCHANGE SAFETY REPORTING With no, or limited, access to actual patient data, trial design is based on models & discussions with expert clinicians. EHR4CR - Enabling protocol testing with real world data in potential trial sites! EHR4CR aims to speed up recruitment by making EHR data searchable for investigators & by establishing a unified communication path between sponsors and sites. EHR4CR facilitates EHR data extraction for applications used during trial execution (e.g. prefilling of CRFs of SAE reports).

Addressing common challenges for the re-use of health data for clinical research Interoperability Infrastructure & Syntax Harmonisation in a Clinical Data Warehouse partially through ETL (Extract Transform and Load) and partially through query mapping in the platform connectors. Semantic Eligibility criteria formalisation using coding-system agnostic query languages for representing eligibility criteria. Use of a Common Information Model. CIM to site specific information models transformation services provide terminology conversion (e.g. PathLex, ICD-10, SNOMED, LOINC, ATC, ), unit conversion, concept expansion, etc. Scalability & Maintainability The platform is a loosely coupled Service Oriented Architecture, use of industry standards is maximised. This architecture ensures scalability and maintainability through modularity. Security & Privacy Security relying on CIAM, an advanced SOA security framework designed for healthcare environments. Confidence in data Data quality monitoring can be built in the site node software based on the EHR4CR query technology.

The EHR4CR Platform Site dependent process (Virtual) appliance Centrally deployed (Saas/Paas) Application Services ETL Messaging Platform Management AuthN Local Applications Terminology Services Semantic interop. Mapping... Workflow Security AuthZ Audit

The EHR4CR platform dataflow HOSPITAL/DATA PROVIDER EHR4CR PLATFORM RESEARCH CENTRE e.g. pharmaceutical company Enabled #Counts >> Recruitment Progress >> Central Feasibility & Recruitment Workbench << Queries << Clinical Trial ETL #Counts >> Trial Candidates Recruitment Workbench Recruitment Progress >> Protocol feasibility Patient recruitment

Where we are now Project pilots Feasibility & Recruitment 12 studies, different therapeutic areas De-identified data from >500k patients over 11 sites Operational pan- European platform Pilot hospitals 11 major hospitals in 5 countries. Germany (WWU, FAU) France (AP-HP, U936) UK (UoD, UoG, UoM, UCL, KCL) Switzerland (HUG) Poland (MuW) Scaling up the solutions! Technology Operations Governance Sustainability Operational pan-european platform Permanent network of clinical sites giving access to millions of patients in close to real time Fully compliant with governing legislation Reaching out to the rest of the world Providing trial design and recruitment supported by real-world evidence on a European scale 10

Services and service model Bringing added value to Clinical Sites (data providers) at an early stage Starting with a simple service offering for Research Organisations Attract more clinical trials Access to trial drugs and innovative care pathways resulting in better patient care delivery Free access to tools to explore and analyse patient data. Support in process towards better data quality visibility and reputation in the scientific community Protocol feasibility services Optimise protocol eligibility criteria by instantaneously testing them out in multiple sites in various countries Directly identify the countries and specific sites to approach for participation Trial recruitment services Distribute trial protocols over multiple sites in a uniform way Track recruitment progress in real time Optimal recruitment due to tools provided to hospitals

Bootstrapping the network Champion Programme Provides a soft entry for all stakeholders (no-risk) Allows to grow confidence and acceptance Basic functionality, but no compromise on security & privacy Goals Further validate and improve technology Define (refine) the rules of engagement for a sustainable ecosystem Start building a network of hospitals Champions are prepared to invest (manpower, time) because they believe that the clinical platform will eventually bring benefits to ALL stakeholders End of EHR4CR (Feb. 2016) 2015 2016 2017 Hospital Champions EFPIA Champion(s) Partnerships Champion Programme Large scale deployment

Champions Clinical Sites (Hospitals) Contribution Assist in connecting to their IT systems and with importing and mapping data Commit to joining the network (when/if milestones are reached) Benefits Early access to technology and ability to use it for internal experiments with clinical data management (IT, mapping of data, etc) Increase reputation in scientific community (demonstrable innovation, publications, etc.) Premium version of local site applications for free Steer development Research Organisations Contribution Bring hospitals to the network Commit to become a customer (when/if milestones are reached) Benefits Favourable service fees Opportunity to prioritise the functionality and flow of the services as they are further developed Steer the growth path with respect to pathology and site selection

Champion Programme As details of Champion Programmes are being worked out, the fieldwork has already started Research organisation Champion shortlist 1st wave candidates: AstraZeneca, Sanofi, Janssen Further interest: Bayer, Amgen, GSK + Pfizer (non EHR4CR partner) Additional collaborations InterSystems - system integrator Clinical site Champion engagement EHR4CR partner hospitals are considering further engagement 1ste wave candidates: APHP, Erlangen, Munster 3 Hospitals outside EHR4CR are already implementing UZ Gent, CHRU Lille, AZ St-Elisabeth Zottegem 1 st wave Pharma is contacting their partner sites

Growing the technology Continuous development as the programme advances and the network is expanded Continuous improvement Reduction of time to connect a site Improve ETL and mapping through tools, standard templates, etc. Standard integration profiles though collaboration with EHR vendors Handling unstructured data Phase I: extract structured data from unstructured (NLP) during import (no core platform change). Phase II: enhance platform with unstructured search. Expand and maintain core dataset Based on clinical trial needs and reality of available data. Improve management tooling.

Summary The coming months will determine whether EHR4CR is just another project or becomes a game changer in the clinical research world Exiting times ahead! 2015 2016 2017 Hospital Champions EFPIA Champion(s) Partnerships

THANK YOU brecht.claerhout@custodix.com